Use of artificial intelligence to diagnose lagophthalmos

A convolutional neural network (CNN) to automate lagophthalmos diagnosis.

Abivax presents first-half 2023 financial results – Biotech Investments

EQS-News: ABIVAX / Key word(s): Half Year Results Abivax presents first-half 2023 financial results 21.09.2023 / 18:00 CET/CEST The issuer is solely responsible for the content

September 22, 2023

Omeros drug fails a PhIII kidney trial, stock nearly halved

Omeros said Monday that its treatment candidate for a certain kidney disease failed a Phase III study, and investors shaved nearly half the share price

October 17, 2023

Incidence and risk factors of an invasive fungal lung infection among COVID-19 patients

Study reveals 0.4%-2.7% incidence of COVID-19-associated pulmonary aspergillosis in severe patients, highlighting significant mortality risks and risk factors.

September 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.